Yet, a very recent study has shown that sustained stimulation and local expansion of Tregs, achieved by using recombinant adeno-associated virus (rAAV) vectors expressing IL-2 at low doses, was able to improve autoimmunity without impairing immune responses to infection, vaccination, cancer development, and pregnancy [82,83]. The gene discussed is IL2; the disease is cancer.